According to Edesa Biotech latest financial reports the cash on hand of EDSA is $5.36M, an decrease of -24.39% to 2022. At the end of 2022 company had $7.09M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $5.36M | -24.39% |
2022 | $7.09M | -9.55% |
2021 | $7.84M | 8.67% |
2020 | $7.21M | 43.40% |
2019 | $5.03M | -51.18% |
2018 | $10.30M | - |